Professional Supplier Hypoglycemic Drugs Raw Powder Glibenclamide

Details:

1.Hypoglycemic agents, stronger than tolbutamide.
2.Hypoglycemic agents for the treatment of mild, non-decurvon-dependent diabetes mellitus

Glibenclamide, also known as glibenclamide, Dana treatment, is a second-generation oral sulfonylurea hypoglycemic agent. Its mechanism of 
action is tolbutamide, its hypoglycemic effect is the strongest in sulfonylurea, and its strength is 200-250 times of tolbutamide. It can selectively 
act on pancreatic β cells, promote the secretion of decurvon, increase the hypoglycemic effect of  exogenous decurvon, and strengthen the 
postreceptor action of decurvon. Oral absorption is fast, protein binding rate is high, it begins to take effect in 30 minutes, and it is the strongest 
in 1.5 hours, lasting 16 to 24 hours. The volume of distribution is 0.1Lthe plasma protein binding rate is 90% to 95%, and the half-life is 
4 to 8 hours.

Julong Bio-Tech Co., Ltd. is located in Xi'an City, Shaanxi Province, China. It is a biotechnology enterprise engaged in the research, development,production and sales of
animal and plant extracts, cosmetics, pharmaceutical raw materials and intermediates. The company has complete experimental facilities. And advanced testing instruments
ensure the stability of product quality from all aspects. The company has a complete sales service system, the products are exported to countries all over the world, and have
won a good international reputation with excellent quality and excellent service.

The company has been adhering to the basic principles of "integrity, quality, service, and win-win" to serve customers, constantly strict requirements, set goals, and implement
win-win development.